Chemical Renal Denervation with Ethanol: First Report of Clinical Trial - Tim Fischell, MD, FSCAI

↳ This is a section part of Moment: CRT 2016 Technology & Innovation - Renal Denervation Treatment for Resistant Hypertension: Innovative Technology Update

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$15.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Preview

Summary

Chemical Renal Denervation with Ethanol: First Report of Clinical Trial presented by Tim Fischell, MD, FSCAI at CRT 2016

Add this Moment to your Passport

Learn from this moment and keep it forever.
add to passport
$15.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Target Audience

  • Interventional Cardiologists
  • Interventional Fellows
  • Physicians with an interest in Resistant Hypertension

Session Name: Renal Denervation Treatment for Resistant Hypertension: Innovative Technology Update

Track: Technology & Innovation

Learning Objectives

Updates in Renal Denervation and Hypertension Therapies 

Other Components in this Moment

Overview
Denervx Microwave for Denervation - Stephan Bertog, MD
Second Generation Symplicity Catheter: Will It Make a Difference? - Justin Davies, BSc, MBBS, PhD
External Ultrasound Technology Update and Clinical Trial - Louis A Cannon, MD, FACC, FACP, FCCP, FSCAI
Chemical Renal Denervation with Ethanol: First Report of Clinical Trial - Tim Fischell, MD, FSCAI
A Self-expanding Carotid Implant - William Gray, MD, FSCAI
Baroreceptor Reflex Stimulation - Sameer Gafoor, MD, FSCAI
Early Clinical Results with the Afferently Directed Non-vascular Renal Denervation System - Rich Heuser, MD, FSCAI
Loading Simple Education